NEW YORK MEDICAL COLLEGE
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1860-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.nymc.edu
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
- Conditions
- Interventions
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- New York Medical College
- Target Recruit Count
- 30
- Registration Number
- NCT04308330
- Locations
- 🇺🇸
New York Medical College, Valhalla, New York, United States
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
- Conditions
- Interventions
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- New York Medical College
- Target Recruit Count
- 40
- Registration Number
- NCT04197596
- Locations
- 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Nationwide Children's Hosptial, Columbus, Ohio, United States
🇺🇸Children's Hospital of Colorado, Aurora, Colorado, United States
The Effect of Platelet-rich Fibrin Matrix on Skin Rejuvenation
- Conditions
- Interventions
- First Posted Date
- 2019-10-16
- Last Posted Date
- 2019-10-22
- Lead Sponsor
- New York Medical College
- Target Recruit Count
- 30
- Registration Number
- NCT04128046
- Locations
- 🇺🇸
New York Medical College, Valhalla, New York, United States
Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder
- Conditions
- Interventions
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- New York Medical College
- Target Recruit Count
- 117
- Registration Number
- NCT04071600
- Locations
- 🇺🇸
Westchester Medical Center, Valhalla, New York, United States
🇺🇸New York Medical College, Valhalla, New York, United States
Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism
- First Posted Date
- 2019-08-01
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- New York Medical College
- Target Recruit Count
- 25
- Registration Number
- NCT04041843
- Locations
- 🇺🇸
New York Medical College, Valhalla, New York, United States
Massively Parallel Sequencing to Identify Microbiological Organisms in Bronchoalveolar Lavage Fluid
- Conditions
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- New York Medical College
- Target Recruit Count
- 10
- Registration Number
- NCT03995030
Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- New York Medical College
- Target Recruit Count
- 20
- Registration Number
- NCT03805581
- Locations
- 🇺🇸
New York Medical College, Valhalla, New York, United States
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
- First Posted Date
- 2018-10-25
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- New York Medical College
- Target Recruit Count
- 40
- Registration Number
- NCT03719105
- Locations
- 🇺🇸
Children's Hospital Orange County, Orange, California, United States
🇺🇸Helen De Vos, Grand Rapids, Michigan, United States
🇺🇸University of Alabama, Birmingham, Alabama, United States
Rifaximin to Modify the Disease Course in Sickle Cell Disease
- First Posted Date
- 2018-10-25
- Last Posted Date
- 2019-03-14
- Lead Sponsor
- New York Medical College
- Target Recruit Count
- 20
- Registration Number
- NCT03719729
- Locations
- 🇺🇸
Westchester Medical Cancer Cancer Institute, Valhalla, New York, United States
Randomized Control Trial: Synchronized Non-invasive Positive Pressure Ventilation Versus Non Synchronized Non Invasive Positive Pressure Ventilation in Extremely Low Birth Weight Infants
- Conditions
- Interventions
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2023-03-27
- Lead Sponsor
- New York Medical College
- Target Recruit Count
- 60
- Registration Number
- NCT03613987
- Locations
- 🇺🇸
Westchester Medical Center, Valhalla, New York, United States